EDRE
ELV icon

Edmond de Rothschild (Europe)’s Elevance Health ELV Stock Holding History

Edmond de Rothschild (Europe)’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,358
Closed -$189K – 238
2016
Q1 		$189K Hold
1,358
– – 0.1% 109
2015
Q4 		$189K Sell
1,358
-122
-8% -$16.8K 0.08% 121
2015
Q3 		$207K Hold
1,480
– – 0.1% 114
2015
Q2 		$243K Buy
+1,480
New +$236K 0.08% 140

Other funds holding ELV

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return

Edmond de Rothschild (Europe)'s ELV Position: Q2 2016 in Review

Edmond de Rothschild (Europe) sold out of Elevance Health (ELV) in Q2 2016, closing a stake of 1,358 shares — an estimated $189K sold.

Edmond de Rothschild (Europe) first reported a position in ELV in Q2 2015 and held it in 4 quarters. The position peaked at $243K in Q2 2015. 760 funds tracked by Wall St. Rank hold ELV as of Q2 2016.

  • Edmond de Rothschild (Europe) reported no remaining Elevance Health position as of Q2 2016 after selling out during the quarter.
  • Edmond de Rothschild (Europe) sold 1,358 Elevance Health shares in Q2 2016, an estimated $189K.
  • Edmond de Rothschild (Europe) first reported a position in Elevance Health in Q2 2015 and held it in 4 quarters.
  • Edmond de Rothschild (Europe)'s Elevance Health position peaked at $243K in Q2 2015.
  • 760 funds tracked by Wall St. Rank held Elevance Health as of Q2 2016.

Based on Edmond de Rothschild (Europe)'s 13F filing for Q2 2016, filed 10 Aug 2016.